Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
14 06 2023
Historique:
received: 09 03 2022
accepted: 07 06 2023
medline: 16 6 2023
pubmed: 15 6 2023
entrez: 14 6 2023
Statut: epublish

Résumé

Human genetics has validated de-repression of fetal gamma globin (HBG) in adult erythroblasts as a powerful therapeutic paradigm in diseases involving defective adult beta globin (HBB)

Identifiants

pubmed: 37316562
doi: 10.1038/s42003-023-05025-4
pii: 10.1038/s42003-023-05025-4
pmc: PMC10267139
doi:

Substances chimiques

Chromatin 0
Fetal Hemoglobin 9034-63-3
NFIX protein, human 0
NFI Transcription Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

640

Informations de copyright

© 2023. The Author(s).

Références

Science. 2008 Dec 19;322(5909):1839-42
pubmed: 19056937
Int J Epidemiol. 2012 Feb;41(1):188-99
pubmed: 22422452
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):E998-1006
pubmed: 24591644
Nat Commun. 2021 Nov 23;12(1):6790
pubmed: 34815405
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Eur J Hum Genet. 2015 May;23(5):610-5
pubmed: 25118028
Sci Rep. 2019 Jun 27;9(1):9354
pubmed: 31249361
Pediatr Res. 2015 Nov;78(5):533-9
pubmed: 26200704
Cell. 2010 Feb 19;140(4):554-66
pubmed: 20178747
Science. 2011 Nov 18;334(6058):993-6
pubmed: 21998251
Blood. 2013 Oct 24;122(17):2987-96
pubmed: 24041575
Bioinformatics. 2011 Apr 1;27(7):1017-8
pubmed: 21330290
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Br J Haematol. 2018 Mar;180(5):630-643
pubmed: 29193029
Nucleic Acids Res. 2009 Jan;37(Database issue):D77-82
pubmed: 18842628
Cell Rep. 2019 Jun 11;27(11):3228-3240.e7
pubmed: 31189107
PLoS Biol. 2022 Jul 19;20(7):e3001683
pubmed: 35853000
Genes Dev. 2017 Aug 15;31(16):1704-1713
pubmed: 28916711
Science. 2013 Oct 11;342(6155):253-7
pubmed: 24115442
Gene. 2000 May 16;249(1-2):31-45
pubmed: 10831836
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell Biol. 1993 Aug;13(8):4632-9
pubmed: 8336706
Nat Commun. 2021 Aug 17;12(1):4991
pubmed: 34404810
Am J Hematol. 2017 Jan;92(1):E2-E3
pubmed: 27701781
Mol Cell Biol. 2007 May;27(10):3855-3867
pubmed: 17353270
PLoS One. 2013;8(3):e59890
pubmed: 23533656
Blood. 2017 Aug 10;130(6):803-807
pubmed: 28659276
Br J Haematol. 2010 Apr;149(2):181-94
pubmed: 20201948
Genome Med. 2015 Jan 20;7(1):1
pubmed: 25606059
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5664-E5672
pubmed: 28652347
Nat Genet. 2015 Nov;47(11):1264-71
pubmed: 26366553
PLoS One. 2015 Mar 17;10(3):e0120102
pubmed: 25780920
Nucleic Acids Res. 2016 Jan 4;44(D1):D110-5
pubmed: 26531826
Cell Rep. 2020 Jun 30;31(13):107832
pubmed: 32610133
J Clin Invest. 2015 Jun;125(6):2363-8
pubmed: 25938782
Dev Cell. 2012 Oct 16;23(4):796-811
pubmed: 23041383
Cell. 2013 Jan 17;152(1-2):327-39
pubmed: 23332764
Blood Adv. 2021 May 11;5(9):2339-2349
pubmed: 33938942
Nucleic Acids Res. 2003 Jan 1;31(1):374-8
pubmed: 12520026
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Nat Genet. 2022 Jun;54(6):874-884
pubmed: 35618846
Stem Cells. 2018 Jun;36(6):943-950
pubmed: 29430853
J Exp Med. 2012 Dec 17;209(13):2467-83
pubmed: 23230003
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
BMC Dev Biol. 2008 May 13;8:52
pubmed: 18477394
Nucleic Acids Res. 2014 Mar;42(5):2976-87
pubmed: 24335146
Mol Ther Methods Clin Dev. 2020 Mar 17;17:589-600
pubmed: 32300607
Nat Biotechnol. 2005 Jan;23(1):69-74
pubmed: 15619619
Nat Genet. 2021 Jun;53(6):869-880
pubmed: 33958780
Science. 2016 Jan 15;351(6270):285-9
pubmed: 26816381
Dev Cell. 2016 Jan 11;36(1):9-23
pubmed: 26766440
Am J Hematol. 2018 Aug;93(4):494-503
pubmed: 29274096
J Hum Genet. 2012 Mar;57(3):207-11
pubmed: 22301465
Cell Rep. 2017 May 23;19(8):1710-1722
pubmed: 28538187
Commun Biol. 2023 Feb 27;6(1):224
pubmed: 36849614
Nat Genet. 2010 Sep;42(9):801-5
pubmed: 20676099
Trends Genet. 2018 Dec;34(12):927-940
pubmed: 30287096

Auteurs

Mudit Chaand (M)

Syros Pharmaceuticals, Cambridge, MA, USA. mchaand@syros.com.

Chris Fiore (C)

Syros Pharmaceuticals, Cambridge, MA, USA.

Brian Johnston (B)

Syros Pharmaceuticals, Cambridge, MA, USA.

Anthony D'Ippolito (A)

Syros Pharmaceuticals, Cambridge, MA, USA.

Diane H Moon (DH)

Syros Pharmaceuticals, Cambridge, MA, USA.

John P Carulli (JP)

Syros Pharmaceuticals, Cambridge, MA, USA.

Jeffrey R Shearstone (JR)

Syros Pharmaceuticals, Cambridge, MA, USA.
Scientific and Medical Writing Partners, Cambridge, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH